Pablo Mozas

32PUBLICATIONS

96CO-AUTHORS

Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jun 08, 2026

Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups.

|Jun 08, 2026

Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.

|Oct 16, 2025

Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report.

Daniel Munarriz, Oriana López-Godino, Nuria Martinez-Cibrian

|Sep 15, 2025

Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma.

Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego

|Mar 03, 2025

A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.

Pablo Mozas, Romain Ould Ammar, Loïc Chartier

|Jan 22, 2025

Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia.

Vicente Chapaprieta, Alba Maiques-Diaz, Ferran Nadeu

Pageof 6

Frequent Collaborators

9 joint publications

Ferran Nadeu

9 joint publications

Armando López-Guillermo

Julio Delgado

Julio Delgado

Elías Campo

Laura Magnano

Silvia Beà

Alex Bataller

Neus Villamor

Juan-Manuel Sancho

Frequent Collaborators

9 joint publications

Ferran Nadeu

9 joint publications

Armando López-Guillermo

8 joint publications

Julio Delgado

8 joint publications

Julio Delgado